The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
about
The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling PathwayImpact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistanceInduction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer.EMT: Present and future in clinical oncology.Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta.Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.The cancer cell adhesion resistome: mechanisms, targeting and translational approaches.The relationship between platinum drug resistance and epithelial-mesenchymal transition.Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells.Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer.β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
P2860
Q36092975-3C8C2E27-82A7-4706-9103-C992C1ECD448Q36731121-479491A4-4D35-400F-AC86-D554C56EA569Q37112458-9155E08F-AB23-49E0-9E77-A84AE7291EC9Q37406832-0EB3D0A4-111D-41CF-A712-32A45C1F5305Q37615676-5C11DA80-4393-45EF-8050-E133A35CE563Q37747413-3690F6C1-C8F7-4B89-8119-DFD7847FEE19Q38673790-2CCFA014-5BB9-4121-9509-87B0E83B5677Q38775246-BFC29A90-B42F-4ABA-BB93-F657FE1CAB93Q38798997-5DA4742C-2153-4320-BE3E-07FF5E560C62Q39046463-E9DE22B7-5810-4457-94C9-BDB1D5F7B417Q39061847-75DAFD1C-E127-4AA9-83F8-11E3D923533EQ41660971-F40C0A8A-B684-48CB-A33D-67A0C8E6B475Q42776839-F274C7F1-2F9F-4BE9-B4C4-7E323AE0C045Q47433075-25B8FD36-99CC-4082-94E0-40E8A0EF2469Q50052675-602A3E2D-5671-452A-A764-DB50FEBF165E
P2860
The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The role of CD29-ILK-Akt signa ...... epatocellular carcinoma cells.
@en
type
label
The role of CD29-ILK-Akt signa ...... epatocellular carcinoma cells.
@en
prefLabel
The role of CD29-ILK-Akt signa ...... epatocellular carcinoma cells.
@en
P2093
P2860
P1433
P1476
The role of CD29-ILK-Akt signa ...... epatocellular carcinoma cells.
@en
P2093
Caiping Ren
Jingxia Wang
Kaili Zhang
Siyuan Tang
Xiaorong Jiang
Yuxiang Chen
P2860
P2888
P356
10.1007/S12032-015-0595-X
P577
2015-03-25T00:00:00Z
P6179
1012603041